METHODS	This study ( conducted April 18 , 2006 , to November 14 , 2007 ) comprised a 24-week , single-blind ( SB ) treatment phase ( gabapentin enacarbil , 1200 mg ) followed by a 12-week randomized , double-blind ( DB ) phase .\